Nexentis Technologies Inc. Common Stock

NXTSNASDAQUSD
5.20 USD
0.73 (12.30%)AT CLOSE (11:59 AM EDT)
5.18
0.03 (0.48%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
5.18
0.03 (0.48%)
🔴Market: CLOSED

Shares of Nexentis Technologies Inc. Common Stock (NXTS) are trading at $5.15. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include negative Return on Equity and a bullish Golden Cross on the moving averages. NXTS is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 25, 2026.

Open?$5.73
High?$5.91
Low?$5.01
Prev. Close?$5.93
Volume?283.6K
Avg. Volume?2.6M
VWAP?$5.48
Rel. Volume?0.11x
Bid / Ask
Bid?$5.10 × 100
Ask?$5.25 × 700
Spread?$0.15
Midpoint?$5.18
Valuation & Ratios
Market Cap?8.6M
Shares Out?730.5K
Float?3.3M
Float %?63.8%
P/E Ratio?N/A
P/B Ratio?0.62
EPS?-$6.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Employees
9
Market Cap
8.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2009-12-15
Address
156 FIFTH AVENUE 10TH FLOOR
NEW YORK, NY 10010-7751
Phone: 972544561349
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.36%Low
Short Interest?11.9K
Days to Cover?1.0
Free Float3.3M
Avg Daily Volume15.3K
Settlement Date2026-06-15
Financial Health
Current Ratio?4.70Strong
Quick Ratio?4.70Strong
Cash Ratio?2.47Strong
Debt/Equity?0.03Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.62CHEAP
P/S?
Peers
100
S&P
3
4,309.13HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.8CHEAP
EV/Sales?
Peers
100
S&P
3
2,393.13HIGH
Returns & Efficiency
ROE?
S&P
3
-67.6%WEAK
ROA?
S&P
3
-57.3%WEAK
Cash Flow & Enterprise
FCF?$-4503000
Enterprise Value?$4.8M
Fundamentals ratios updated end of day